Monday, December 22, 2025 12/22/2025

Aging, sleep, and kynurenic acid

Award Number: R21AG080335
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/15/2023
PERIOD OF PERFORMANCE END DATE: 01/31/2026

Group Awards By:

View Award Description

Aging, sleep, and kynurenic acid - Advanced age presents challenges that increase the likelihood of poor quality and reduced duration of sleep. Disruptions in sleep that come with aging may result in effects such as fatigue, irritability, headaches, and deteriorating cognition. These disruptions are presumed to result from alterations in brain regions that underlie endocrine, behavioral and cognitive responses to homeostatic challenges in the organism. Unraveling common molecular mechanisms between aging and sleep disturbances – which may lead to new therapeutic strategies to alleviate these outcomes – is of great importance. Aging pathophysiology points to dysfunctional cholinergic transmission, which may be driven, in part, by altered hypothalamic orexin neurons. We hypothesize that kynurenic acid (KYNA), an endogenous antagonist of cholinergic neurotransmission, plays a mechanistic role in age-related sleep dysfunction and orexin activation. The small molecule KYNA is of particular interest because (i) KYNA and its synthesizing enzymes kynurenine aminotranferases (KATs) are increased in the aging brain and (ii) an excess of KYNA may be especially involved in sleep deficits that are seen with advanced age. We propose the novel hypothesis that accumulated KYNA activates orexin neurons, thereby disrupting sleep, a circumstance that is exacerbated with aging or a homeostatic sleep deprivation (SD) challenge wherein KYNA accumulates in the brain. A specific inhibitor of KAT II, main enzyme responsible for brain KYNA formation, will be used as an experimental tool to mechanistically test the hypothesis. There are two specific aims to test our hypothesis. Aim #1: To examine the relationship of KYNA to orexinergic activation in the lateral hypothalamus of young rats (3-4 months) and old rats (26-28 months). Hypothesis: Accumulation of KYNA, as a result of aging or acute sleep deprivation (SD), in the lateral hypothalamus activates orexin neurons. Aim #2: To evaluate the impact of KYNA synthesis inhibition in improving sleep quality in old rats and young rats with reduced orexin expression. Hypothesis: KAT II inhibition serves as an efficacious strategy to overcome sleep architecture deficits in old rats and young rats with reduced orexinergic signaling.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	UNIVERSITY OF SOUTH CAROLINA	1600 HAMPTON ST	COLUMBIA	SC	29208	RICHLAND	USA	Aging Research	000	2	12/23/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $186,250 )
2024	2024	UNIVERSITY OF SOUTH CAROLINA	1600 HAMPTON ST	COLUMBIA	SC	29208	RICHLAND	USA	Aging Research	001	2	6/21/2024	NON-COMPETING CONTINUATION	$18,625
2024	2024	UNIVERSITY OF SOUTH CAROLINA	1600 HAMPTON ST # 414	COLUMBIA	SC	29208	RICHLAND	USA	Aging Research	000	2	1/17/2024	NON-COMPETING CONTINUATION	$167,625
														Subtotal = $186,250

Issue Date FY: 2023 ( Subtotal = $223,500 )
2023	2023	UNIVERSITY OF SOUTH CAROLINA	1600 HAMPTON ST # 414	COLUMBIA	SC	29208	RICHLAND	USA	Aging Research	000	1	2/3/2023	NEW	$223,500
														Subtotal = $223,500

Grand Total All Awards = $409,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Aging, sleep, and kynurenic acid

Award Number: R21AG080335

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/15/2023

PERIOD OF PERFORMANCE END DATE: 01/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer